These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102 [TBL] [Abstract][Full Text] [Related]
5. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice. Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537 [TBL] [Abstract][Full Text] [Related]
6. Prospecting the influenza hemagglutinin to develop universal vaccines. Donis RO; Cox NJ Clin Infect Dis; 2011 Apr; 52(8):1010-2. PubMed ID: 21460315 [No Abstract] [Full Text] [Related]
9. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits. Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575 [TBL] [Abstract][Full Text] [Related]
10. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs. Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C Vaccine; 2012 Apr; 30(20):3119-25. PubMed ID: 22391400 [TBL] [Abstract][Full Text] [Related]
11. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure. Wei CJ; Yassine HM; McTamney PM; Gall JG; Whittle JR; Boyington JC; Nabel GJ Sci Transl Med; 2012 Aug; 4(147):147ra114. PubMed ID: 22896678 [TBL] [Abstract][Full Text] [Related]
12. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines. Settembre EC; Dormitzer PR; Rappuoli R J Mol Cell Biol; 2011 Jun; 3(3):144-6. PubMed ID: 21430014 [TBL] [Abstract][Full Text] [Related]
13. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner. Sambhara V J Infect Dis; 2011 Jun; 203(11):1697-8. PubMed ID: 21593002 [No Abstract] [Full Text] [Related]
14. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age. Baxter R; Patriarca PA; Ensor K; Izikson R; Goldenthal KL; Cox MM Vaccine; 2011 Mar; 29(12):2272-8. PubMed ID: 21277410 [TBL] [Abstract][Full Text] [Related]
15. Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. Sabarth N; Howard MK; Savidis-Dacho H; van Maurik A; Barrett PN; Kistner O Vaccine; 2010 Jan; 28(3):650-6. PubMed ID: 19896446 [TBL] [Abstract][Full Text] [Related]
16. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Lee VJ; Tay JK; Chen MI; Phoon MC; Xie ML; Wu Y; Lee CX; Yap J; Sakharkar KR; Sakharkar MK; Lin RT; Cui L; Kelly PM; Leo YS; Tan YJ; Chow VT Vaccine; 2010 Oct; 28(42):6852-7. PubMed ID: 20723626 [TBL] [Abstract][Full Text] [Related]
17. Characterization of antibodies specific for hemagglutinin and neuraminidase proteins of the 1918 and 2009 pandemic H1N1 viruses. Liu Y; Liu X; Fang J; Shen X; Chen W; Lin X; Li H; Tan W; Wang Y; Zhao P; Qi Z Vaccine; 2010 Dec; 29(2):183-90. PubMed ID: 21055499 [TBL] [Abstract][Full Text] [Related]
18. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia. Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232 [TBL] [Abstract][Full Text] [Related]
19. One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies. Faenzi E; Zedda L; Bardelli M; Spensieri F; Borgogni E; Volpini G; Buricchi F; Pasini FL; Capecchi PL; Montanaro F; Belli R; Lattanzi M; Piccirella S; Montomoli E; Ahmed SS; Rappuoli R; Del Giudice G; Finco O; Castellino F; Galli G Vaccine; 2012 Jun; 30(27):4086-94. PubMed ID: 22521851 [TBL] [Abstract][Full Text] [Related]
20. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets. Pillet S; Kobasa D; Meunier I; Gray M; Laddy D; Weiner DB; von Messling V; Kobinger GP Vaccine; 2011 Sep; 29(39):6793-801. PubMed ID: 21211587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]